MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.310 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
1
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Mood Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
580
|
308
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Idiopathic pulmonary arterial hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
776
|
24
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Familial primary pulmonary hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
30
|
2
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hematopoetic Myelodysplasia
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
38
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pulmonary Hypertension, Primary, 1
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
9
|
323
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Pulmonary Hypertension, Primary, Fenfluramine-Associated
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
3
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Heart Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
537
|
45
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Right Ventricular Hypertrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
160
|
6
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Amputated structure (morphologic abnormality)
|
phenotype |
Wounds and Injuries
|
Acquired Abnormality
|
94
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Deformity
|
group |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Anatomical Abnormality
|
350
|
26
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Prostatic Intraepithelial Neoplasias
|
disease |
Neoplasms
|
Neoplastic Process
|
230
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Laryngeal Squamous Cell Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
504
|
30
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Malignant Bone Neoplasm
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
125
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of gastrointestinal tract
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
423
|
55
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Central Serous Chorioretinopathy
|
disease |
Eye Diseases
|
Disease or Syndrome
|
211
|
10
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hyperplastic Polyp
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
204
|
22
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
296
|
9
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Peritoneal Fibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
104
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |